Poland· PL-100248056
Oculosan
A naphazolin, kombinationen product containing naphazolini nitras + zinci sulfas, registered in Poland by Laboratoires Thea. The same ATC class is registered in 6 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Naphazolin, kombinationen is registered in 6 of 19 countries.
Countries holding a registration under ATC S01GA51 (naphazolin, kombinationen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Naphazolin, kombinationen · ATC S01GA51
6 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Ireland
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Naphazolini nitras + Zinci sulfas
- Manufacturer
- Laboratoires Thea
- Country
- Poland (PL)
- ATC code
- S01GA51
- ATC class
- Naphazolin, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990145416
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under S01GA51
Naphazolin, kombinationen, as other registers publish it.
- FinlandAntistin-PrivinNovartis Healthcare A/S
- FinlandAntistin-PrivinNovartis Consumer Health SA
- DenmarkAntistina-privinLaboratoires Thea S.A.S.
- PolandBetadrinWarszawskie Zakłady Farmaceutyczne POLFA S.A.
- CanadaCLEAR EYES ALLERGYPRESTIGE BRANDS INC
- CanadaCLEAR EYES EXTRA STRENGTH REDNESS RELIEFPRESTIGE BRANDS INC
- CanadaNAPHCON AALCON CANADA INC
- BelgiumNaphcon-A 3 mg/ml - 0.25 mg/mlAlcon
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Greece · Zabysept
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b0fa1475-1df6-46fd-a123-13847b1f3951 GET /v1/drugs/b0fa1475-1df6-46fd-a123-13847b1f3951?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople do oczu, roztwór",
"source": "urpl",
"strength": "(0,05 mg + 0,2 mg)/ml",
"packaging": "05909990145416 ¦ OTC ¦ 46839\n1 fl. 10 ml",
"substance": "Naphazolini nitras 0.05 mg/ml + Zinci sulphas 0.2 mg/ml + Zinci sulphas 0.2 mg/ml + Naphazolini nitras 0.05 mg/ml",
"common_name": "Naphazolini nitras + Zinci sulfas",
"pl_product_id": "100248056",
"pozwolenie_nr": "01454",
"auth_procedure": "NAR",
"authorisation_validity": "2024-05-14"
}See everything about naphazolin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.